We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Halliburton (HAL) Q1 Earnings Beat Estimates, Sales Miss Mark
Read MoreHide Full Article
Earnings: World’s No. 2 oilfield-services company Halliburton Company (HAL - Free Report) reported first quarter adjusted net income per share of 31 cents, beating the Zacks Consensus Estimate of 25 cents.
Estimate Revision Trend & Surprise History: Investors should note that the Zacks Consensus Estimate for the quarter has been unchanged in the last 60 days.
Nonetheless, Halliburton have a decent earnings surprise history. The company beat/matched estimates in two of the prior four quarters, as shown in the chart below:
Overall, the company has a positive earnings surprise of 6.75% in the trailing four quarters.
Revenues: Halliburton posted revenues of $5 billion, which were lower than the year-ago quarter figure of $5.7 billion and missed the Zacks Consensus Estimate by 0.8%.
Key Stats: Operating income from the Completion & Production segment was $345 million, lower than the year-ago level of $368 million. Our current consensus estimates called for a lower operating income of $344 million.
Halliburton’s Drilling & Evaluation unit profit improved from $123 million in the first quarter of 2019 to $217 million this year. Moreover, the number was above the Zacks Consensus Estimate of $164 million.
Zacks Rank: Currently, Halliburton carries a Zacks Rank #3 (Hold).
Check back later for our full write up on this Halliburton earnings report later!
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
Image: Bigstock
Halliburton (HAL) Q1 Earnings Beat Estimates, Sales Miss Mark
Earnings: World’s No. 2 oilfield-services company Halliburton Company (HAL - Free Report) reported first quarter adjusted net income per share of 31 cents, beating the Zacks Consensus Estimate of 25 cents.
Estimate Revision Trend & Surprise History: Investors should note that the Zacks Consensus Estimate for the quarter has been unchanged in the last 60 days.
Nonetheless, Halliburton have a decent earnings surprise history. The company beat/matched estimates in two of the prior four quarters, as shown in the chart below:
Halliburton Company Price and EPS Surprise
Halliburton Company price-eps-surprise | Halliburton Company Quote
Overall, the company has a positive earnings surprise of 6.75% in the trailing four quarters.
Revenues: Halliburton posted revenues of $5 billion, which were lower than the year-ago quarter figure of $5.7 billion and missed the Zacks Consensus Estimate by 0.8%.
Key Stats: Operating income from the Completion & Production segment was $345 million, lower than the year-ago level of $368 million. Our current consensus estimates called for a lower operating income of $344 million.
Halliburton’s Drilling & Evaluation unit profit improved from $123 million in the first quarter of 2019 to $217 million this year. Moreover, the number was above the Zacks Consensus Estimate of $164 million.
Zacks Rank: Currently, Halliburton carries a Zacks Rank #3 (Hold).
(You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.)
Check back later for our full write up on this Halliburton earnings report later!
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>